Shandong Xinhua Pharmaceutical Company Limited

SEHK:719 Stok Raporu

Piyasa değeri: HK$9.7b

Shandong Xinhua Pharmaceutical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Shandong Xinhua Pharmaceutical şirketinin toplam hissedar öz sermayesi CN¥5.1B ve toplam borcu CN¥1.7B olup, bu da borç-öz sermaye oranını 32.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥8.8B ve CN¥3.7B dir. Shandong Xinhua Pharmaceutical 'in FAVÖK'ü CN¥491.2M faiz karşılama oranı -340 dur. Şirketin CN¥1.2B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

32.5%

Borç/özkaynak oranı

CN¥1.66b

Borç

Faiz karşılama oranı-340x
NakitCN¥1.16b
EşitlikCN¥5.10b
Toplam yükümlülüklerCN¥3.73b
Toplam varlıklarCN¥8.82b

Son finansal sağlık güncellemeleri

Recent updates

Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Jun 28
Shandong Xinhua Pharmaceutical (HKG:719) Is Paying Out A Larger Dividend Than Last Year

Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Jan 23
Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Mar 07
Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 18
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Jul 27
These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Jul 04
Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

Mar 09
Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Dec 21
We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

Apr 06
Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Mar 19
What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Feb 26
Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 05
Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Jan 18
Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Dec 29
Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Dec 14
Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 26
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 719 'nin kısa vadeli varlıkları ( CN¥3.6B ) kısa vadeli yükümlülüklerini ( CN¥2.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: 719 şirketinin kısa vadeli varlıkları ( CN¥3.6B ) uzun vadeli yükümlülüklerini ( CN¥1.0B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 719 'nin net borç/öz sermaye oranı ( 9.8% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 719 'nin borç/öz sermaye oranı son 5 yılda 47.7% seviyesinden 32.5% seviyesine düştü.

Borç Kapsamı: 719 'nin borcu işletme nakit akışı ( 26.8% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 719 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.


Bilanço


Sağlıklı şirketleri keşfedin